Skip Main Navigation
Page Content
This event has ended

Save This Event

Event Saved

National Conference on the Consequences of Sodium Valproate (Epilim): 50 years on

Epilepsy Ireland

Friday, 22 March 2019 from 09:30 to 17:00 (GMT)

National Conference on the Consequences of Sodium...

Registration Information

Type Remaining End Quantity
General Admission 11 Registrations Ended Free  

Share National Conference on the Consequences of Sodium Valproate (Epilim): 50 years on

Event Details

National Conference on
The consequences of Sodium Valproate (Epilim)
50 years on

 For patients & families affected by valproate exposure, healthcare professionals and policy makers

Organised by the Health Service Executive, Epilepsy Ireland, OACS Ireland, Trinity College Dublin and the FACS Forum

Friday March 22nd 2019
9.30am – 5pm

Stanley Quek Theatre
Biomedical Sciences Institute | Trinity College Dublin
152-160 Pearse Street | Dublin 2

 

Sodium Valproate (Epilim) is a medication used to treat epilepsy and bipolar disorder. The European Medicines Agency has restricted its use in women due to the increased risk of disabilities in children exposed to Valproate in the womb (Foetal Valproate Syndrome).

This conference will address the key issues today facing families, healthcare professionals and policy makers in:

  • The pharmacology of sodium valproate
  • Sodium valproate: Who knew what and when?
  • Reducing the risks associated with sodium valproate
  • Diagnosing and managing foetal valproate syndrome
  • Living with foetal valproate syndrome and the consequences of sodium valproate
  • The Irish Health Service’s response to the valproate problem

Speakers include:

  • Dr Colm Henry, HSE Chief Clinical Officer
  • Karen Keely, Chairperson, OACS Ireland
  • Dr Jeff Aronson, Clinical Pharmacologist, Centre for Evidence-Based Medicine, Oxford
  • Prof. Carl Heneghan, Director of the Centre for Evidence-Based Medicine, Oxford
  • Prof. Amanda Wood, Professor of Developmental Neuropsychology, Aston University, Birmingham
  • Dr Peter Turnpenny, Clinical Geneticist, Royal Devon & Exeter Hospital, UK
  • Prof. Andrew Green, Consultant Clinical Geneticist, Our Lady's Children's Hospital, Crumlin
  • Families affected by Foetal Valproate Syndrome
  • Members of the HSE’s Valproate Response project team

For further information, please contact:

Sabrina Doyle, HSE: 01 6352508 | sabrina.doyle@hse.ie

Do you have questions about National Conference on the Consequences of Sodium Valproate (Epilim): 50 years on? Contact Epilepsy Ireland

When & Where


Stanley Quek Theatre
Biomedical Sciences Institute, 152-160 Pearse Street,
Trinity College Dublin
D02 R590 Dublin 2
Ireland

Friday, 22 March 2019 from 09:30 to 17:00 (GMT)


  Add to my calendar

Organiser

Epilepsy Ireland

This event is jointly organised by the HSE, Epilepsy Ireland, OACS Ireland, Trinity College Dublin and the FACS Forum.


  Contact the Organiser

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.